1 – 10 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
(
- Contribution to journal › Article
-
Mark
Exploring the thermodynamic and kinetic landscape of amyloid fibril formation
2025)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
(
- Contribution to journal › Article
-
Mark
Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
(
- Contribution to journal › Article
- 2024
-
Mark
Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
(
- Contribution to journal › Article
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
(
- Contribution to journal › Article
-
Mark
Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions
(
- Contribution to journal › Article
-
Mark
Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer’s disease continuum
(
- Contribution to journal › Article